• Decoding Mutational Drivers and Drug Resistance in Myeloma C

  2026-07-15

  This article explores the comprehensive exome-wide analysis of multiple myeloma cell lines presented by Vikova et al., which uncovers novel and established mutational drivers linked to tumor progression and drug resistance. The findings offer researchers an advanced framework for selecting cell line models and inform strategies to overcome heterogeneity and therapeutic resistance in hematological malignancy research.

• Triptolide (PG490): Transcriptional Condensate Disruption in

  2026-07-14

  Explore how Triptolide (PG490) uniquely disrupts transcriptional condensates and impairs tumor cell plasticity, drawing on recent condensate biology research. This article advances the conversation beyond cell viability, providing a deep mechanistic and translational perspective for cancer research applications.

• Dimethyloxalylglycine (DMOG): Protocols & Technical Guidance

  2026-07-14

  Dimethyloxalylglycine (DMOG) enables controlled stabilization of hypoxia-inducible factor (HIF) proteins for in vitro and in vivo modeling of hypoxia signaling and inflammation. This compound is optimized for laboratory workflows investigating oxygen sensing and immune modulation, but is not suitable for diagnostic or clinical applications.

• Redefining mRNA Vaccine Design: Mechanisms & Kit Selection

  2026-07-13

  Explore how mechanistic advances in immune-evasive mRNA vaccine engineering, exemplified by spleen-targeted neoantigen strategies in hepatocellular carcinoma, are reshaping translational research. This thought-leadership article links bench-top innovation with strategic product choice, spotlighting the HyperScribe™ All in One mRNA Synthesis Kit Plus 1 for robust, immune-silent, and translationally potent mRNA synthesis.

• Amikacin Disulfate: Deep Mechanisms and Protein Interaction

  2026-07-13

  Explore how Amikacin disulfate, a semisynthetic aminoglycoside antibiotic, uniquely shapes protein–antibiotic interactions and informs advanced assay design. This article delivers a deeper mechanistic analysis, drawing on recent fluorescence and tritium probe findings, to guide more predictive bacterial resistance research.

• STING agonist-1: Precision Tool for STING Pathway Activation

  2026-07-12

  STING agonist-1 is a high-purity small molecule designed to activate the STING pathway, enabling robust studies of innate immunity and B cell-driven antitumor responses. Its validated mechanism and analytical characterization position it as a reliable immunology research reagent. APExBIO supplies this compound for rigorous cancer immunotherapy and inflammation signaling research.

• Metronidazole in Research: OAT3 Inhibition & Microbiota Modu

  2026-07-10

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) is not just a cornerstone for anaerobic bacteria targeting—it’s a potent OAT3 inhibitor, enabling advanced studies of drug transport and microbiome-immune interplay. This article details experimental workflows, troubleshooting strategies, and the translational impact of APExBIO’s high-purity Metronidazole for research use.

• 5-hme-dCTP: Precision Epigenetic DNA Modification Workflows

  2026-07-09

  5-hme-dCTP enables high-resolution mapping and functional interrogation of 5-hydroxymethylcytosine in plant genomes, directly supporting advanced epigenetic DNA modification research. Drawing on the latest drought response study in rice, this guide details optimized workflows, troubleshooting, and strategic integration for robust DNA hydroxymethylation assays using APExBIO’s high-purity nucleotide analog.

• Isoprinosine in Viral Immunotherapy: Protocols, Assay Advanc

  2026-07-09

  Isoprinosine (inosine pranobex) uniquely bridges immunomodulation and direct viral inhibition, empowering researchers to tackle acute respiratory and herpesvirus infections with robust, reproducible workflows. This article decodes advanced experimental strategies, highlights key innovations from emerging nuclear egress research, and delivers actionable troubleshooting guidance for optimized antiviral studies.

• Mutational Landscapes in Myeloma Cell Lines: Implications fo

  2026-07-08

  This study delivers the first comprehensive exome-wide map of mutations in human multiple myeloma cell lines, revealing key driver genes and pathways linked to tumor progression and drug resistance. The findings enable more precise model selection for preclinical research and guide the strategic development of targeted therapies.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ) in Extrahepatic Immunotherapy

  2026-07-08

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) empowers immunology researchers to deliver potent cytokine signals with precision and low innate immune activation. Its advanced m1Ψ and Cap 1 modifications, combined with biomimetic delivery strategies, enable robust gene expression in extrahepatic tissues for next-generation immunotherapy studies.

• 8-Chloroadenosine: High-Purity Nucleoside Analog for RNA Stu

  2026-07-07

  8-Chloroadenosine is a nucleoside analog that potently inhibits RNA synthesis and supports advanced transcriptional regulation research. Its high purity, solubility in DMSO, and validated role in RNA metabolism studies make it a preferred molecular biology reagent for precise interrogation of lncRNA and cancer models.

• Sunitinib: Multi-Targeted Receptor Tyrosine Kinase Inhibitor

  2026-07-07

  Sunitinib empowers researchers to dissect angiogenesis, apoptosis, and cell cycle dynamics in renal cell carcinoma and other tumor models. This guide delivers protocol precision, troubleshooting insights, and the latest breakthroughs on synergy with bioactive compounds.

• Ceftolozane/Tazobactam: Novel Options Against Resistant Path

  2026-07-06

  Ceftolozane/tazobactam represents a significant advance in the treatment of complicated intraabdominal and urinary tract infections, particularly those caused by multidrug-resistant gram-negative bacteria. This review highlights its mechanism, clinical evidence, and comparative advantages, offering insight into emerging strategies for combating antimicrobial resistance.

• Hyaluronic Acid Sodium Salt (SKU B8382): Solutions for Relia

  2026-07-06

  Discover how Hyaluronic acid sodium salt (SKU B8382) empowers reproducible cell viability and nanoparticle delivery workflows. This article delivers scenario-driven strategies, referencing quantitative data and peer-reviewed studies, to optimize assay reliability in biomedical research using APExBIO's validated biopolymer.

16343 records 1/1090 page Next 12345 下5页 Last page